Insider buying
~$20K14K sh @ $1.49
First insider buy since Nov 2020Traded Nov 10, 2025 · filed 2 days later
Since the trade −98.6% · S&P 500 +1.2% · to Nov 20
Bought 99% below the 52-week high, RSI 52, 91% under its 200-day average, 30 points behind the S&P 500 over 3 months
An Aptevo Therapeutics director paid $20K out of pocket for Aptevo Therapeutics shares. Shares held went up 1351300% with this purchase.